Oncomfort has won the 2021 Award for Most Disruptive Innovator

Oncomfort has won the Deloitte’s 2021 award for Most Disruptive Innovator.  This award is part of the Rising Star selection in the Deloitte Technology Fast 50 competition and is designed for promising companies that have been active in the technology sector for less than four years. The announcement was made at the Technology Fast 50 Awards Ceremony on 25 November 2021.

Oncomfort - Digital Sedation™ is a completely new method for relieving patients’ pain and anxiety before, during and after medical procedures. This revolutionising digital therapy combines clinical hypnotherapy and integrative therapeutic techniques through Virtual Reality.

“We are honoured surprised to have won the Deloitte’s 2021 Most Disruptive Innovator award. It’s exciting to know that we are the fastest-growing company in the sector and that we are on the right path for continued growth.”